Sonoma Pharmaceuticals (SNOA) Deferred Taxes (2022 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Deferred Taxes of -$93000.0 in Q2 2025, up 50.53% quarter-over-quarter from -$188000.0 in Q1 2025, and up 23.77% on a YoY basis from -$75139.1 in Q2 2024.
Sonoma Pharmaceuticals (SNOA) Deferred Taxes (2022 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' Deferred Taxes history runs 4 years deep, the most recent figure standing at -$93000.0 for Q2 2025.
- In Q2 2025, Deferred Taxes rose 23.77% year-over-year to -$93000.0; the TTM figure through Jun 2025 stood at -$328000.0 (down 525.97% YoY), while the FY2025 annual figure was -$357000.0, down 427.52% from the prior year.
- Deferred Taxes was -$93000.0 for Q2 2025 at Sonoma Pharmaceuticals, up from -$188000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $829000.0 in Q1 2022 to a low of -$188000.0 in Q1 2025.
- Historically, Deferred Taxes has averaged $37500.0 across 4 years, with a median of -$60000.0 in 2023.
- The sharpest annual moves came in 2023 and 2025: Deferred Taxes jumped 149.52% in 2023, then sank 193.53% in 2025.
- A 4-year view of Deferred Taxes shows it stood at -$105000.0 in 2022, then surged by 149.52% to $52000.0 in 2023, then plunged by 63.46% to $19000.0 in 2024, then tumbled by 589.47% to -$93000.0 in 2025.
- The last three Deferred Taxes figures came in at -$93000.0 (Q2 2025), -$188000.0 (Q1 2025), and $19000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -22.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 34.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 25.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 14,341.73 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -61.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -8.79 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -13.98 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 19.33 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -93,000.00 |
| Mar 31, 2025 | -188,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Sep 30, 2024 | -66,000.00 |
| Jun 30, 2024 | -122,000.00 |
| Mar 31, 2024 | 201,000.00 |
| Dec 31, 2023 | 52,000.00 |
| Sep 30, 2023 | -54,000.00 |
| Jun 30, 2023 | -90,000.00 |
| Mar 31, 2023 | 281,000.00 |
| Dec 31, 2022 | -105,000.00 |
| Sep 30, 2022 | -99,000.00 |
| Jun 30, 2022 | -40,000.00 |
| Mar 31, 2022 | 829,000.00 |